- Home
- MLYS vs ADSE Comparison
MLYS vs ADSE Comparison
Compare MLYS & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- ADSE
- Stock Information
- Founded
- MLYS 2019
- ADSE 1980
- Country
- MLYS United States
- ADSE Ireland
- Employees
- MLYS N/A
- ADSE N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- ADSE Industrial Specialties
- Sector
- MLYS Health Care
- ADSE Consumer Discretionary
- Exchange
- MLYS Nasdaq
- ADSE Nasdaq
- Market Cap
- MLYS 609.7M
- ADSE 705.5M
- IPO Year
- MLYS 2023
- ADSE N/A
- Fundamental
- Price
- MLYS $12.34
- ADSE $13.98
- Analyst Decision
- MLYS Strong Buy
- ADSE Hold
- Analyst Count
- MLYS 2
- ADSE 1
- Target Price
- MLYS $30.00
- ADSE $14.00
- AVG Volume (30 Days)
- MLYS 163.5K
- ADSE 78.7K
- Earning Date
- MLYS 11-11-2024
- ADSE 09-12-2024
- Dividend Yield
- MLYS N/A
- ADSE N/A
- EPS Growth
- MLYS N/A
- ADSE N/A
- EPS
- MLYS N/A
- ADSE N/A
- Revenue
- MLYS N/A
- ADSE $158,974,606.00
- Revenue This Year
- MLYS N/A
- ADSE $98.67
- Revenue Next Year
- MLYS N/A
- ADSE $47.66
- P/E Ratio
- MLYS N/A
- ADSE N/A
- Revenue Growth
- MLYS N/A
- ADSE 168.42
- 52 Week Low
- MLYS $7.37
- ADSE $6.25
- 52 Week High
- MLYS $16.91
- ADSE $15.01
- Technical
- Relative Strength Index (RSI)
- MLYS 47.76
- ADSE 53.62
- Support Level
- MLYS $11.19
- ADSE $13.75
- Resistance Level
- MLYS $12.57
- ADSE $14.30
- Average True Range (ATR)
- MLYS 0.80
- ADSE 0.51
- MACD
- MLYS -0.06
- ADSE 0.02
- Stochastic Oscillator
- MLYS 43.07
- ADSE 74.19
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services which enable the customer to control and manage the system. Geographically, it derives a majority of its revenue from Europe.